Literature DB >> 7939069

[Diagnosis and therapy of portosystemic encephalopathy].

K Weissenborn1.   

Abstract

With respect to the grade of disturbance of consciousness on one hand and concomitant cognitive, psychic and neuromuscular symptoms on the other hand several stages of portosystemic encephalopathy (PSE) are differentiated; moreover, it could recently be demonstrated that a remarkable proportion of cirrhotics without any clinical sign of cerebral dysfunction shows pathological results in psychometric and neurophysiological examinations. Therefore, the stage of subclinical, latent PSE was defined additionally. The assessment of subclinical PSE is usually done using paper-pencil tests or neurophysiological examinations like the EEG. The diagnosis of manifest PSE is made with respect to clinical criteria. Other possible causes of cerebral dysfunction have to be excluded by laboratory, neurological and eventually radiological examination. Therapy of PSE aims at the reduction production and resorption of ammonia. New therapeutic approaches, which have been proposed with regard to pathophysiological aspects of PSE other than ammonia, have not yet been established.

Entities:  

Mesh:

Year:  1994        PMID: 7939069

Source DB:  PubMed          Journal:  Schweiz Rundsch Med Prax        ISSN: 1013-2058


  1 in total

1.  Quantification of the electroencephalographic theta/alpha ratio for the assessment of portal-systemic encephalopathy following implantation of transjugular intrahepatic portosystemic stent shunt (TIPSS).

Authors:  Erik Bahn; Wilhelm Nolte; Christoph Kurth; Giuliano Ramadori; Eckhard Rüther; Jens Wiltfang
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.